Biofrontera Inc. (BFRIW)
0.07
-0.03 (-29.93%)
At close: Mar 03, 2025, 3:59 PM
0.06
-17.14%
After-hours: Mar 03, 2025, 03:59 PM EST
No 1D chart data available
| Bid | 0.05 |
| Market Cap | 6.06M |
| Revenue (ttm) | 682.18M |
| Net Income (ttm) | -247.74M |
| EPS (ttm) | -1.296 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.07 |
| Volume | 1,643 |
| Avg. Volume (20D) | 14,640.117 |
| Open | 0.07 |
| Previous Close | 0.10 |
| Day's Range | 0.07 - 0.07 |
| 52-Week Range | 0.07 - 0.07 |
| Beta | 0.30 |
About BFRIW
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xe...
Sector Healthcare
IPO Date n/a
Employees 83
Stock Exchange NASDAQ
Ticker Symbol BFRIW
Website https://www.biofrontera-us.com